Status:
UNKNOWN
Neonatal Complications of Coronavirus Disease (COVID-19)
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
Imperial College London
University of Leicester
Conditions:
Neonatal COVID-19 Disease
Eligibility:
All Genders
1-29 years
Brief Summary
There is an evidence gap in relation to the incidence, impact and severity of COVID-19 in newborn babies. International data are very limited, we have no robust estimates of incidence and no UK-based ...
Detailed Description
The investigators have established a national (UK-wide) active surveillance study using the standard British Paediatric Surveillance Unit (BPSU) approach. Since the 1st April 2020 case notifications ...
Eligibility Criteria
Inclusion
- Any baby:
- That has a diagnosis of COVID-19 made on a sample taken before 29 days of age and receives inpatient care for COVID-19 (this includes postnatal ward, neonatal unit, paediatric inpatient wards, PICU) OR
- Where the mother had confirmed COVID-19 at the time of birth or suspected COVID-19 at the time of birth that has subsequently been confirmed, and the baby was admitted for neonatal care
Exclusion
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04386109
Start Date
April 1 2020
End Date
September 30 2021
Last Update
May 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College
London, United Kingdom